Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Healthy Volunteers
Disease Category: Healthy Patient Studies
Location: United States, AZ

Clinical Trial Details

Overview

Research Study Summary

Clinical trial for Patients with lupus

Purpose

This clinical trial is provided by Antidote.

This study is for people with CLE (cutaneous lupus erythematosus) and/or SLE (systemic lupus erythematosus). People with certain types of lupus may experience skin rashes, sores, scarring, or inflammation. The investigational drug in this study targets the specific cells involved in causing these skin symptoms. This study will evaluate whether this drug can reduce these skin issues in patients with CLE, and also decrease overall lupus symptoms, such as fatigue and joint pain, in patients with SLE .

This study has an online pre-screener.

To Learn more

CW ID: 224479
Date Last Changed: September 1, 2017

Clinical Trial Snapshot

Phase
2
Gender
Both Male and Female
Age
18 to 75 Years
Overall Status
Recruiting
Lead Sponsor
Biogen
Duration
40 Days
Facility Type
N/A

Eligibility

  • Subjects must Have a diagnosis of SLE (systemic lupus erythematosus) and/or CLE (cutaenous lupus erythematosus).
  • Subjects must Have a current skin issue due to lupus
  • Subjects must not Have lupus nephritis or chronic kidney disease
  • Subjects must not Be taking certain biologic medications

More Info

This study has an online pre-screener.

Contact

This study has an online pre-screener.

Sam Haddad
Arizona Arthritis & Rheumatology Research
Located in:
Phoenix, AZ 85037

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.